Prospective Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Sep 21, 2022; 28(35): 5217-5229
Published online Sep 21, 2022. doi: 10.3748/wjg.v28.i35.5217
Table 1 Antibody and antigen biomarkers for hepatitis B and hepatitis C infections

Chronic HBV
Resolved HBV
HBV vaccinated
HBV Susceptible
Chronic HCV
HBsAgPosNegNegNegPos/neg
HBcAbPosPosNegNegPos/neg
HBsAbNegPos/indeter/negPosNeg/indeterPos/neg
Anti-HCVNeg/posNeg/posNeg/posNeg/posPos

  • Citation: Mohamed EA, Giama NH, Abdalla AO, Shaleh HM, Oseini AM, Ali HA, Ahmed F, Taha W, Ahmed Mohammed H, Cvinar J, Waaeys IA, Ali H, Allotey LK, Ali AO, Mohamed SA, Harmsen WS, Ahmmad EM, Bajwa NA, Afgarshe MD, Shire AM, Balls-Berry JE, Roberts LR. High prevalence of chronic viral hepatitis B and C in Minnesota Somalis contributes to rising hepatocellular carcinoma incidence. World J Gastroenterol 2022; 28(35): 5217-5229
  • URL: https://www.wjgnet.com/1007-9327/full/v28/i35/5217.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v28.i35.5217